The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The event will be attended by 35,000+ industry professionals
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Subscribe To Our Newsletter & Stay Updated
